Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Netris Pharma S.A.S.

Headquarters: Lyon, France
Year Founded: 2008
Status: Private

BioCentury | Mar 12, 2025
Discovery & Translation

Science Spotlight: Killing the mesenchymal precursors that drive cancer progression

BioCentury’s roundup of translational innovations also includes blood detection of pregnancy complications, BBB-crossing antibodies, and more
BioCentury | Aug 11, 2023
Discovery & Translation

Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 19, 2017
Product Development

Restoring dependence

How Netris’ dependence receptor programs kill cancer stem cells missed by other drugs
BioCentury | Mar 29, 2017
Clinical News

NP137: Ph I started

BioCentury | Apr 3, 2008
Distillery Therapeutics

This Week in Therapeutics

Items per page:
1 - 6 of 6